• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    Amicus Therapeutics, Inc. (FOLD)

    -NasdaqGM
    8.31 0.35(4.40%) Jan 23, 4:00PM EST
    Add to Portfolio
    Prev Close:7.96
    Open:7.90
    Bid:8.00 x 600
    Ask:8.31 x 4100
    1y Target Est:11.50
    Beta:3.06
    Earnings Date:Mar 2 - Mar 6 (Est.)
    Day's Range:7.85 - 8.32
    52wk Range:1.77 - 9.63
    Volume:978,477
    Avg Vol (3m):1,911,260
    Market Cap:659.16M
    P/E (ttm):N/A
    EPS (ttm):-0.90
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for FOLD

    Comparison

    Symbol% ChgMkt Cap
    FOLDUp 4.40%659.16M
    SHPG42.31B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):407.88
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.87
    Quarterly EPS Est (Dec-14) :-0.18
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback